Also, in view of our previous studies demonstrating the SCD5-dependent intracellular retention of SPARC and considering the known involvement of SPARC itself in supporting a mesenchymal-like phenotype, we looked for the possible SCD5 capability in reversing the EMT-like process in melanoma. This evidence concerns the gene SCD5 and melanoma.